All articles tagged with #dolly the sheep
Thirty years after Dolly, cloning is a costly, inefficient tool—not a simple paste‑and‑copy of life—used to reproduce valuable livestock, aid conservation and advance disease research, aided by epigenetic reprogramming and the rise of induced pluripotent stem cells; while de‑extinction ideas surface, human cloning remains unsafe and tightly regulated.
Ian Wilmut, the embryologist who famously cloned Dolly the sheep in 1996, has passed away at the age of 79. His groundbreaking work challenged the belief that genetic instructions were lost when cells specialized, opening up new possibilities in regenerative medicine. Wilmut's research paved the way for the production of transgenic animals and the growth of replacement cells and tissues. He became a global spokesperson for science, advocating for clear limits on scientific endeavors based on legal, ethical, and regulatory principles. Despite his self-effacing nature, Wilmut leaves behind a legacy of transformed biology and a public willingness to explore biological complexity.
Ian Wilmut, the British scientist who led the team that successfully cloned Dolly the sheep in 1996, has passed away at the age of 79 after a long battle with Parkinson's disease. The birth of Dolly, the world's first cloned mammal, shocked the scientific community and raised ethical questions about cloning. Wilmut's groundbreaking work in genetic engineering and cloning has left a lasting impact on the field of science.
Ian Wilmut, the British scientist who led the team that successfully cloned Dolly the Sheep in 1996, has passed away at the age of 79. His groundbreaking work sparked a global debate on the ethics of cloning and opened up possibilities for regenerative medicine. Wilmut's research team at the University of Edinburgh's Roslin Institute created the first genetically identical mammal from an adult cell, paving the way for future advancements in cloning and stem cell research.